Amylyx Pharmaceuticals News

Amylyx Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Bedrosian Camille L

Dec 3 17:26 ET

Amylyx Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-The Vanguard Group(4.53%)

Nov 12 13:29 ET

Amylyx Pharmaceuticals | 10-Q: Q3 2024 Earnings Report

Nov 7 08:28 ET

Amylyx Pharmaceuticals | 8-K: Amylyx Pharmaceuticals Reports Third Quarter 2024 Financial Results

Nov 7 07:09 ET

Amylyx Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Klee Justin B.

Nov 6 19:27 ET

Amylyx Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-The Vanguard Group(4.53%)

Nov 4 11:00 ET

Amylyx Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-Perceptive Advisors LLC(6.5%),Joseph Edelman(6.5%), etc.

Oct 25 17:42 ET

Amylyx Pharmaceuticals | 8-K: Current report

Oct 17 09:16 ET

Amylyx Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Klee Justin B.

Oct 2 18:59 ET

Amylyx Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Cohen Joshua B

Oct 2 18:59 ET

Amylyx Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Bedrosian Camille L

Oct 2 18:54 ET

Amylyx Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Mazzariello Gina

Oct 2 18:49 ET

Amylyx Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Cohen Joshua B

Sep 25 18:00 ET

Amylyx Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Cohen Joshua B

Sep 16 17:42 ET

Amylyx Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer FRATES JAMES M

Sep 16 17:32 ET

Amylyx Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Firestone Karen

Sep 9 16:06 ET

Amylyx Pharmaceuticals | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Officer FRATES JAMES M

Sep 5 19:58 ET

Amylyx Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director MILNE GEORGE M JR

Sep 5 19:28 ET

Amylyx Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-TCG Crossover GP II, LLC(6.8%),TCG Crossover Fund II, L.P.(6.8%), etc.

Aug 26 18:51 ET

Amylyx Pharmaceuticals | 10-Q: Q2 2024 Earnings Report

Aug 8 07:19 ET